0
0
Home » Medical Devices » General Surgery » Aesthetic Devices

Aesthetic Injectables Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies,2022 Update

Aesthetic injectables refer to gel-like substances that are injected beneath the skin to restore a more youthful appearance. GlobalData's Medical Devices sector report, “Aesthetic Injectables Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update" provides comprehensive information about the Aesthetic Injectables pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

The Aesthetic Injectables report provides key information and data related to:

Extensive coverage of the Aesthetic Injectables under development

Review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths, and estimated approval dates

Reviews of major players involved in the pipeline product development.

Provides key clinical trial data related to ongoing clinical trials such as trial phase, trial status, trial start and end dates, and the number of trials of the major Aesthetic Injectables pipeline products.

Review of Recent Developments in the segment / industry

The Aesthetic Injectables report enables you to:

Access significant competitor information, analysis, and insights to improve your R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage

Identify and understand important and diverse types of Aesthetic Injectables under development

Formulate market-entry and market expansion strategies

Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

The GlobalData Differentiation

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

The data and analysis within this report are driven by GlobalData Medical Intelligence Center (GDMIC) database. GDMIC gives you the key information required to drive sales, investment and deal-making activity in your business. It includes the following:

• 15,000+ data tables showing market size across more than 780 medical equipment segments and 39 countries, from 2015 and forecast to 2025

• 6,700+ industry-leading analysis reports covering sector reports, medipoint reports, country analysis, expert insights and industry analysis (devices and procedures) reports

• 64,000+ medical equipment company profiles

• 5,600+ company profiles of medical equipment manufacturers in China and India

• 2,200+ company profiles of medical equipment manufacturers in Japan

• 1,200+ companies’ revenue splits and market shares

• 1,600+ quarterly and annual medical equipment company financials

• 850+ medical equipment company SWOTs

• 28,000+ pipeline product profiles

• 56,400+ marketed product profiles

• 47,000+ clinical trials

• 41,500+ trial investigators

• 7,000+ reports on companies with products in development

• 44,000+ deals in the medical equipment industry

• 1,100+ surgical and diagnostic procedures by therapy area

• 50+ key healthcare indicators by country

• 431,000+ Themes Content Items

• 600+ Influencers

• 1,900+ Analysts & Researchers

• 0.5m+ Community Members

• 141,000+ Macroeconomic Indicators

• 1,013,000+ City Indicators

For more information or to receive a free demonstration of the service, please visit:

https://medical.globaldata.com/home.aspx

Custom Requirements

Contact us to discuss the areas of your business where you need external input, and we will work with you to identify the strongest way forward to meet your needs.

Scope

– Extensive coverage of the Aesthetic Injectables under development

– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

– The report reviews the major players involved in the development of Aesthetic Injectables and list all their pipeline projects

– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

– The report provides key clinical trial data of ongoing trials specific to pipeline products

– Recent developments in the segment / industry

Reasons to Buy

The report enables you to:

– Formulate significant competitor information, analysis, and insights to improve R&D strategies

– Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage

– Identify and understand important and diverse types of Aesthetic Injectables under development

– Develop market-entry and market expansion strategies

– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

– In-depth analysis of the product’s current stage of development, territory and estimated launch date

Key Players

Acro Biomedical Co Ltd

Advanced Aesthetic Technologies Inc

Aeon Astron Corporation

Aesthetic Medical Device

Allergan Aesthetics

Almirall Ltd

BioPlus Co Ltd

Bioxis Pharmaceuticals

BMG Pharma SpA

Bmi Korea Co Ltd

CellPraxis

Celltrix AB

Collplant Biotechnologies Ltd

Dexlevo Inc

EternoGen Aesthetics LLC

Fillmed Laboratoires

Genzyme Corp

Hallura Ltd

Histogen Inc

Hugel Inc

Innovia LLC

Juvenis Ltd

Khorionyx SA

LG Chem Ltd

LifeSprout Inc

Medytox Inc

Merz North America Inc

Mesoestetic Pharma Group SL

Moma Therapeutics Inc

N8 Medical LLC

Oligo Medic Inc

PB&B SA

PetVivo Holdings Inc

Q-Med AB

Revance Therapeutics Inc

Samyang Biopharmaceuticals Corp

Sebana Medical Ltd

Shanghai Haohai Biological Technology Co Ltd

Shin Poong Pharm Co Ltd

Silk Medical Aesthetics Inc

Sinclair Pharma Ltd

Sofregen Medical Inc

SunMax Biotechnology Co Ltd

TEI Biosciences Inc

Tempo Therapeutics Inc

Teoxane SA

Tissueform Inc

University of California Santa Barbara

Table of Contents

1 Table of Contents

2 Introduction 13

2.1 Aesthetic Injectables Overview 13

3 Products under Development 14

3.1 Aesthetic Injectables – Pipeline Products by Stage of Development 14

3.2 Aesthetic Injectables – Pipeline Products by Segment 15

3.3 Aesthetic Injectables – Pipeline Products by Territory 16

3.4 Aesthetic Injectables – Pipeline Products by Regulatory Path 17

3.5 Aesthetic Injectables – Pipeline Products by Estimated Approval Date 18

3.6 Aesthetic Injectables – Ongoing Clinical Trials 19

4 Aesthetic Injectables – Pipeline Products under Development by Companies 20

4.1 Aesthetic Injectables Companies – Pipeline Products by Stage of Development 20

4.2 Aesthetic Injectables – Pipeline Products by Stage of Development 23

5 Aesthetic Injectables Companies and Product Overview 26

5.1 Acro Biomedical Co Ltd Company Overview 26

5.1.1 Acro Biomedical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 26

5.2 Advanced Aesthetic Technologies Inc Company Overview 27

5.2.1 Advanced Aesthetic Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 27

5.3 Aeon Astron Corporation Company Overview 30

5.3.1 Aeon Astron Corporation Pipeline Products & Ongoing Clinical Trials Overview 30

5.4 Aesthetic Medical Device Company Overview 31

5.4.1 Aesthetic Medical Device Pipeline Products & Ongoing Clinical Trials Overview 31

5.5 Allergan Aesthetics Company Overview 34

5.5.1 Allergan Aesthetics Pipeline Products & Ongoing Clinical Trials Overview 34

5.6 Almirall Ltd Company Overview 46

5.6.1 Almirall Ltd Pipeline Products & Ongoing Clinical Trials Overview 46

5.7 BioPlus Co Ltd Company Overview 47

5.7.1 BioPlus Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 47

5.8 Bioxis Pharmaceuticals Company Overview 50

5.8.1 Bioxis Pharmaceuticals Pipeline Products & Ongoing Clinical Trials Overview 50

5.9 BMG Pharma SpA Company Overview 53

5.9.1 BMG Pharma SpA Pipeline Products & Ongoing Clinical Trials Overview 53

5.10 Bmi Korea Co Ltd Company Overview 55

5.10.1 Bmi Korea Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 55

5.11 CellPraxis Company Overview 56

5.11.1 CellPraxis Pipeline Products & Ongoing Clinical Trials Overview 56

5.12 Celltrix AB Company Overview 57

5.12.1 Celltrix AB Pipeline Products & Ongoing Clinical Trials Overview 57

5.13 Collplant Biotechnologies Ltd Company Overview 58

5.13.1 Collplant Biotechnologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 58

5.14 Dexlevo Inc Company Overview 59

5.14.1 Dexlevo Inc Pipeline Products & Ongoing Clinical Trials Overview 59

5.15 EternoGen Aesthetics LLC Company Overview 60

5.15.1 EternoGen Aesthetics LLC Pipeline Products & Ongoing Clinical Trials Overview 60

5.16 Fillmed Laboratoires Company Overview 61

5.16.1 Fillmed Laboratoires Pipeline Products & Ongoing Clinical Trials Overview 61

5.17 Genzyme Corp Company Overview 66

5.17.1 Genzyme Corp Pipeline Products & Ongoing Clinical Trials Overview 66

5.18 Hallura Ltd Company Overview 67

5.18.1 Hallura Ltd Pipeline Products & Ongoing Clinical Trials Overview 67

5.19 Histogen Inc Company Overview 71

5.19.1 Histogen Inc Pipeline Products & Ongoing Clinical Trials Overview 71

5.20 Hugel Inc Company Overview 72

5.20.1 Hugel Inc Pipeline Products & Ongoing Clinical Trials Overview 72

5.21 Innovia LLC Company Overview 76

5.21.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 76

5.22 Juvenis Ltd Company Overview 77

5.22.1 Juvenis Ltd Pipeline Products & Ongoing Clinical Trials Overview 77

5.23 Khorionyx SA Company Overview 78

5.23.1 Khorionyx SA Pipeline Products & Ongoing Clinical Trials Overview 78

5.24 LG Chem Ltd Company Overview 79

5.24.1 LG Chem Ltd Pipeline Products & Ongoing Clinical Trials Overview 79

5.25 LifeSprout Inc Company Overview 89

5.25.1 LifeSprout Inc Pipeline Products & Ongoing Clinical Trials Overview 89

5.26 Medytox Inc Company Overview 92

5.26.1 Medytox Inc Pipeline Products & Ongoing Clinical Trials Overview 92

5.27 Merz North America Inc Company Overview 95

5.27.1 Merz North America Inc Pipeline Products & Ongoing Clinical Trials Overview 95

5.28 Mesoestetic Pharma Group SL Company Overview 98

5.28.1 Mesoestetic Pharma Group SL Pipeline Products & Ongoing Clinical Trials Overview 98

5.29 Moma Therapeutics Inc Company Overview 99

5.29.1 Moma Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 99

5.30 N8 Medical LLC Company Overview 100

5.30.1 N8 Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 100

5.31 Oligo Medic Inc Company Overview 101

5.31.1 Oligo Medic Inc Pipeline Products & Ongoing Clinical Trials Overview 101

5.32 PB&B SA Company Overview 102

5.32.1 PB&B SA Pipeline Products & Ongoing Clinical Trials Overview 102

5.33 PetVivo Holdings Inc Company Overview 103

5.33.1 PetVivo Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 103

5.34 Q-Med AB Company Overview 105

5.34.1 Q-Med AB Pipeline Products & Ongoing Clinical Trials Overview 105

5.35 Revance Therapeutics Inc Company Overview 110

5.35.1 Revance Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 110

5.36 Samyang Biopharmaceuticals Corp Company Overview 111

5.36.1 Samyang Biopharmaceuticals Corp Pipeline Products & Ongoing Clinical Trials Overview 111

5.37 Sebana Medical Ltd Company Overview 115

5.37.1 Sebana Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 115

5.38 Shanghai Haohai Biological Technology Co Ltd Company Overview 116

5.38.1 Shanghai Haohai Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 116

5.39 Shin Poong Pharm Co Ltd Company Overview 117

5.39.1 Shin Poong Pharm Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 117

5.40 Silk Medical Aesthetics Inc Company Overview 118

5.40.1 Silk Medical Aesthetics Inc Pipeline Products & Ongoing Clinical Trials Overview 118

5.41 Sinclair Pharma Ltd Company Overview 122

5.41.1 Sinclair Pharma Ltd Pipeline Products & Ongoing Clinical Trials Overview 122

5.42 Sofregen Medical Inc Company Overview 126

5.42.1 Sofregen Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 126

5.43 SunMax Biotechnology Co Ltd Company Overview 129

5.43.1 SunMax Biotechnology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 129

5.44 TEI Biosciences Inc Company Overview 134

5.44.1 TEI Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 134

5.45 Tempo Therapeutics Inc Company Overview 135

5.45.1 Tempo Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 135

5.46 Teoxane SA Company Overview 136

5.46.1 Teoxane SA Pipeline Products & Ongoing Clinical Trials Overview 136

5.47 Tissueform Inc Company Overview 139

5.47.1 Tissueform Inc Pipeline Products & Ongoing Clinical Trials Overview 139

5.48 University of California Santa Barbara Company Overview 140

5.48.1 University of California Santa Barbara Pipeline Products & Ongoing Clinical Trials Overview 140

6 Aesthetic Injectables- Recent Developments 141

6.1 Nov 17, 2021: Silk Medical Aesthetics announces feasibility clinical trial results for its all-natural dermal filler 141

7 Appendix 142

7.1 Methodology 142

7.2 About GlobalData 145

7.3 Contact Us 145

7.4 Disclaimer 145

List of Tables

Aesthetic Injectables – Pipeline Products by Stage of Development 14

Aesthetic Injectables – Pipeline Products by Segment 15

Aesthetic Injectables – Pipeline Products by Territory 16

Aesthetic Injectables – Pipeline Products by Regulatory Path 17

Aesthetic Injectables – Pipeline Products by Estimated Approval Date 18

Aesthetic Injectables – Ongoing Clinical Trials 19

Aesthetic Injectables Companies – Pipeline Products by Stage of Development 20

Aesthetic Injectables – Pipeline Products by Stage of Development 23

Acro Biomedical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 26

ACROFILL – Product Status 26

ACROFILL – Product Description 26

Advanced Aesthetic Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 27

Algeness VL – Product Status 27

Algeness VL – Product Description 27

Advanced Aesthetic Technologies Inc – Ongoing Clinical Trials Overview 28

Algeness VL – A Pivotal Clinical Study to Evaluate the Effectiveness and Safety of Algeness VL for the Correction of Moderate to Severe Nasolabial Folds 29

Algeness VL – A Prospective, Multi-center, Randomized, Controlled, Single-blind Study of the Safety and Effectiveness of Algeness DF 3.5% Deep Volumizing Filler to Correct Age-related Volume Deficit in the Mid-face 29

Aeon Astron Corporation Pipeline Products & Ongoing Clinical Trials Overview 30

BioDermal Filler – Product Status 30

BioDermal Filler – Product Description 30

Aesthetic Medical Device Pipeline Products & Ongoing Clinical Trials Overview 31

Alluris – Product Status 31

Alluris – Product Description 31

Skinlumina – Product Status 32

Skinlumina – Product Description 32

SkinTechMD – Product Status 32

SkinTechMD – Product Description 33

Allergan Aesthetics Pipeline Products & Ongoing Clinical Trials Overview 34

AAM SubQ Body Filler – Product Status 34

AAM SubQ Body Filler – Product Description 35

ADM Subdermal Body Filler – Product Status 35

ADM Subdermal Body Filler – Product Description 35

Elastagen – Acne Scars – Product Status 35

Elastagen – Acne Scars – Product Description 36

Elastagen – Skin Quality – Product Status 36

Elastagen – Skin Quality – Product Description 36

HA Threads – Product Status 36

HA Threads – Product Description 37

Juvederm – Decolletage – Product Status 37

Juvederm – Decolletage – Product Description 37

Juvederm – Hands – Product Status 37

Juvederm – Hands – Product Description 38

Juvederm – Neck Lines – Product Status 38

Juvederm – Neck Lines – Product Description 38

Juvederm RejuveCross – Deep Wrinkles – Product Status 38

Juvederm RejuveCross – Deep Wrinkles – Product Description 39

Juvederm RejuveCross – Etched Lines Wrinkles – Product Status 39

Juvederm RejuveCross – Etched Lines Wrinkles – Product Description 39

Juvederm RejuveCross Volumize – Cheek Augmentation – Product Status 39

Juvederm RejuveCross Volumize – Cheek Augmentation – Product Description 40

Juvederm Voluma – Nose – Product Status 40

Juvederm Voluma – Nose – Product Description 40

Juvederm Voluma – Temple – Product Status 40

Juvederm Voluma – Temple – Product Description 41

Juvederm Voluma Global – Malar Augmentation – Product Status 41

Juvederm Voluma Global – Malar Augmentation – Product Description 41

rhCollagen Dermal Filler – Product Status 42

rhCollagen Dermal Filler – Product Description 42

rhCollagen Soft Tissue Filler – Product Status 42

rhCollagen Soft Tissue Filler – Product Description 42

Allergan Aesthetics – Ongoing Clinical Trials Overview 43

Juvederm Voluma Global – Malar Augmentation – A Prospective, Multi-center, Randomized, Controlled, Single-blind Study of the Safety and Effectiveness of Algeness DF 3.5% Deep Volumizing Filler to Correct Age-related Volume Deficit in the Mid-face 44

Juvederm Voluma Global – Malar Augmentation – Clinical, Instrumental and Histological Evaluation of the Combined Use of Onabotulinumtoxin A and Hyaluronic Acid Fillers in Patients with Facial Paralysis 44

Juvederm Voluma – Temple – A Multicenter, Evaluator-blinded, Randomized, No-treatment Controlled Study to Evaluate the Safety and Effectiveness of Juvederm Voluma with Lidocaine for Correction of Temple Hollowing in Chinese Population 45

Almirall Ltd Pipeline Products & Ongoing Clinical Trials Overview 46

Hyaluronic Acid Facial Filler – Product Status 46

Hyaluronic Acid Facial Filler – Product Description 46

BioPlus Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 47

Biological Breast – Product Status 47

Biological Breast – Product Description 47

Hyaluronic Acid Filler – Bio-cartilage Replacement – Product Status 48

Hyaluronic Acid Filler – Bio-cartilage Replacement – Product Description 48

Hyaluronic Acid Filler – Bladder Tissue Repair – Product Status 48

Hyaluronic Acid Filler – Bladder Tissue Repair – Product Description 49

Bioxis Pharmaceuticals Pipeline Products & Ongoing Clinical Trials Overview 50

Cytosmile – Product Status 50

Cytosmile – Product Description 50

MTI-12 – Product Status 51

MTI-12 – Product Description 51

MTI-12 – Surgical Repair – Product Status 51

MTI-12 – Surgical Repair – Product Description 52

BMG Pharma SpA Pipeline Products & Ongoing Clinical Trials Overview 53

SGA300 – Product Status 53

SGA300 – Product Description 53

SGA302 – Product Status 54

SGA302 – Product Description 54

Bmi Korea Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 55

BMI4002 – Product Status 55

BMI4002 – Product Description 55

CellPraxis Pipeline Products & Ongoing Clinical Trials Overview 56

Lipage – Product Status 56

Lipage – Product Description 56

Celltrix AB Pipeline Products & Ongoing Clinical Trials Overview 57

Credurance – Product Status 57

Credurance – Product Description 57

Collplant Biotechnologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 58

Dermal Filler – Product Status 58

Dermal Filler – Product Description 58

Dexlevo Inc Pipeline Products & Ongoing Clinical Trials Overview 59

Gouri – Product Status 59

Gouri – Product Description 59

EternoGen Aesthetics LLC Pipeline Products & Ongoing Clinical Trials Overview 60

Cellifique – Product Status 60

Cellifique – Product Description 60

Fillmed Laboratoires Pipeline Products & Ongoing Clinical Trials Overview 61

ART FILLER FINE LINES – Product Status 61

ART FILLER FINE LINES – Product Description 61

ART FILLER LIPS – Product Status 62

ART FILLER LIPS – Product Description 62

ART FILLER LIPS SOFT – Product Status 62

ART FILLER LIPS SOFT – Product Description 63

ART FILLER UNIVERSAL – Product Status 63

ART FILLER UNIVERSAL – Product Description 63

ART FILLER VOLUME – Product Status 64

ART FILLER VOLUME – Product Description 64

NCTF 135 – Product Status 64

NCTF 135 – Product Description 65

NCTF 135 HA – Product Status 65

NCTF 135 HA – Product Description 65

Genzyme Corp Pipeline Products & Ongoing Clinical Trials Overview 66

Prevelle Lift – Product Status 66

Prevelle Lift – Product Description 66

Hallura Ltd Pipeline Products & Ongoing Clinical Trials Overview 67

BiOLinkMatrix Gel – Product Status 67

BiOLinkMatrix Gel – Product Description 67

Hyaluronic Acid Dermal Filler – Product Status 68

Hyaluronic Acid Dermal Filler – Product Description 68

Hallura Ltd – Ongoing Clinical Trials Overview 69

BiOLinkMatrix Gel – Prospective, Interventional, Non-randomized, Open Label Study for the Evaluation of the Safety and Performance of an Injectable Hyaluronic Acid Filler 70

Histogen Inc Pipeline Products & Ongoing Clinical Trials Overview 71

HST002 – Product Status 71

HST002 – Product Description 71

Hugel Inc Pipeline Products & Ongoing Clinical Trials Overview 72

The Chaeum Pure No.1 – Product Status 72

The Chaeum Pure No.1 – Product Description 73

The Chaeum Pure No.2 – Product Status 73

The Chaeum Pure No.2 – Product Description 73

The Chaeum Pure No.3 – Product Status 74

The Chaeum Pure No.3 – Product Description 74

The Chaeum Pure No.4 – Product Status 74

The Chaeum Pure No.4 – Product Description 75

The Chaeum Style – Product Status 75

The Chaeum Style – Product Description 75

Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 76

Wrinkle Filler – Product Status 76

Wrinkle Filler – Product Description 76

Juvenis Ltd Pipeline Products & Ongoing Clinical Trials Overview 77

Tenergel – Product Status 77

Tenergel – Product Description 77

Khorionyx SA Pipeline Products & Ongoing Clinical Trials Overview 78

Autologous Globin Dermal Filler – Product Status 78

Autologous Globin Dermal Filler – Product Description 78

LG Chem Ltd Pipeline Products & Ongoing Clinical Trials Overview 79

LR19059 – Product Status 79

LR19059 – Product Description 80

LR19093 – Product Status 80

LR19093 – Product Description 80

LR20008 – Product Status 80

LR20008 – Product Description 81

LR20023 – Product Status 81

LR20023 – Product Description 81

LR20024 – Product Status 82

LR20024 – Product Description 82

YVOIRE Y-Solution 360 – Product Status 82

YVOIRE Y-Solution 360 – Product Description 83

YVOIRE Y-Solution 540 – Product Status 83

YVOIRE Y-Solution 540 – Product Description 83

YVOIRE Y-Solution 720 – Product Status 84

YVOIRE Y-Solution 720 – Product Description 84

LG Chem Ltd – Ongoing Clinical Trials Overview 85

YVOIRE Y-Solution 360 – A Multicenter, Prospective Observational Study to Evaluate the Incidence of Delayed-onset Nodules of YVOIRE Y-Solution 360, YVOIRE Y-Solution 540 or YVOIRE Y-Solution 720 Injected Into the Facial Skin Layer 86

YVOIRE Y-Solution 360 – A Multicenter, Randomized, Rater-Blinded, No-Treatment Control Design Clinical Investigation to Evaluate the Effectiveness and Safety of YVOIRE Y-Solution 360 for Lip Augmentation 86

YVOIRE Y-Solution 540 – A Multicenter, Prospective Observational Study to Evaluate the Incidence of Delayed-onset Nodules of YVOIRE Y-Solution 360, YVOIRE Y-Solution 540 or YVOIRE Y-Solution 720 Injected Into the Facial Skin Layer 87

YVOIRE Y-Solution 540 – A Randomized, Multicenter, Evaluator-blinded, Active-controlled, Parallel-group Design Investigation to Evaluate the Effectiveness and Safety of YVOIRE Y-Solution 540 Versus YVOIRE Volume Plus in Nasolabial Folds Injection 87

YVOIRE Y-Solution 720 – A Multicenter, Prospective Observational Study to Evaluate the Incidence of Delayed-onset Nodules of YVOIRE Y-Solution 360, YVOIRE Y-Solution 540 or YVOIRE Y-Solution 720 Injected Into the Facial Skin Layer 88

YVOIRE Y-Solution 720 – A Multicenter, Randomized, Evaluator-blinded, No-treatment Control Design Clinical Study to Evaluate the Effectiveness and Safety of YVOIRE Y-Solution 720 Injected for Jawline Contouring 88

YVOIRE Y-Solution 720 – A Multicenter, Randomized, Rater-blinded, No-treatment Control Design Clinical Study to Evaluate the Effectiveness and Safety of YVOIRE Y-Solution 720 Injected Into the Mid-face 88

LifeSprout Inc Pipeline Products & Ongoing Clinical Trials Overview 89

Lumina – Product Status 89

Lumina – Product Description 89

LifeSprout Inc – Ongoing Clinical Trials Overview 90

Lumina – A Prospective, Randomized, Controlled, Multi-center Study of the Safety and Effectiveness of Lumina in the Treatment of Nasolabial Folds 91

Medytox Inc Pipeline Products & Ongoing Clinical Trials Overview 92

MT943 – Product Status 92

MT943 – Product Description 92

Neuramis Deep Lidocaine – Product Status 93

Neuramis Deep Lidocaine – Product Description 93

Neuramis Volume Lidocaine – Product Status 93

Neuramis Volume Lidocaine – Product Description 94

Merz North America Inc Pipeline Products & Ongoing Clinical Trials Overview 95

VP1 Lido US – Product Status 95

VP1 Lido US – Product Description 95

Merz North America Inc – Ongoing Clinical Trials Overview 96

VP1 Lido US – A Prospective, Multicenter, Randomized, Comparator-controlled, Evaluator-blinded Study to Evaluate the Safety and Effectiveness of VP1 Lido US for Volume Augmentation of the Cheek 97

Mesoestetic Pharma Group SL Pipeline Products & Ongoing Clinical Trials Overview 98

mRDX-02-17 – Product Status 98

mRDX-02-17 – Product Description 98

Moma Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 99

Restogel – 131 – Product Status 99

Restogel – 131 – Product Description 99

N8 Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 100

Ceragenin-Infused Dermal Filler – Product Status 100

Ceragenin-Infused Dermal Filler – Product Description 100

Oligo Medic Inc Pipeline Products & Ongoing Clinical Trials Overview 101

AntaRep – Product Status 101

AntaRep – Product Description 101

PB&B SA Pipeline Products & Ongoing Clinical Trials Overview 102

PB&B Facial Volumizer – Product Status 102

PB&B Facial Volumizer – Product Description 102

PetVivo Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 103

CosmetaLife – Product Status 103

CosmetaLife – Product Description 103

Dermal Filler – Lip – Product Status 104

Dermal Filler – Lip – Product Description 104

Q-Med AB Pipeline Products & Ongoing Clinical Trials Overview 105

GAL1906 – Product Status 105

GAL1906 – Product Description 105

GP0112 – Product Status 106

GP0112 – Product Description 106

Q-Med AB – Ongoing Clinical Trials Overview 107

GAL1906 – A Randomized, Evaluator-blinded, No-treatment Controlled, Multicenter Study to Evaluate the Effectiveness and Safety of GAL1906 for Correction of Wrinkles in the décolletage Area 108

GP0112 – A Randomized, Evaluator-blinded, Parallel Group, Comparator-controlled, Multicenter Study to Evaluate the Safety and Effectiveness of GP0112 for Cheek Augmentation and Correction of Midface Contour Deficiencies 109

Revance Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 110

RHA Redensity – Product Status 110

RHA Redensity – Product Description 110

Samyang Biopharmaceuticals Corp Pipeline Products & Ongoing Clinical Trials Overview 111

Aesthetic Filler – Product Status 111

Aesthetic Filler – Product Description 111

SYB Filler (SF-01) – Product Status 112

SYB Filler (SF-01) – Product Description 112

Samyang Biopharmaceuticals Corp – Ongoing Clinical Trials Overview 113

SYB Filler (SF-01) – A Randomized, Subject and Evaluator-blind, Matched Pairs, Prospective Study to Compare the Safety and Efficacy Between SYB Filler (SF-01) and Ellanse M in the Correction of Nasolabial Folds 114

Sebana Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 115

Dermal Filler – Product Status 115

Dermal Filler – Product Description 115

Shanghai Haohai Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 116

QST Gel – Product Status 116

QST Gel – Product Description 116

Shin Poong Pharm Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 117

FreeWink – Product Status 117

FreeWink – Product Description 117

Silk Medical Aesthetics Inc Pipeline Products & Ongoing Clinical Trials Overview 118

Dermal Filler – Product Status 118

Dermal Filler – Product Description 118

SMA-001 – Product Status 119

SMA-001 – Product Description 119

Silk Medical Aesthetics Inc – Ongoing Clinical Trials Overview 120

Dermal Filler – A Feasibility Clinical Trial of All-natural Dermal Filler for Nasolabial Folds 121

Sinclair Pharma Ltd Pipeline Products & Ongoing Clinical Trials Overview 122

Atlean – Product Status 122

Atlean – Product Description 122

Ellanse Lidocaine – Product Status 123

Ellanse Lidocaine – Product Description 123

MaiLi – Product Status 123

MaiLi – Product Description 124

Perfectha G – Product Status 124

Perfectha G – Product Description 124

Perfectha Lips – Product Status 125

Perfectha Lips – Product Description 125

Sofregen Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 126

Silk Protein – Tissue/Dermal Filler – Product Status 126

Silk Protein – Tissue/Dermal Filler – Product Description 126

Sofregen Medical Inc – Ongoing Clinical Trials Overview 127

Silk Protein – Tissue/Dermal Filler – A Feasibility Study to Evaluate Preliminary Safety and Effectiveness of SMI-01 as a Tissue Filler 128

SunMax Biotechnology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 129

Sunmax FACIALGAIN Collagen Implant With Lidocaine – Product Status 129

Sunmax FACIALGAIN Collagen Implant With Lidocaine – Product Description 129

Sunmax FULLSGEN With Lidocaine – Product Status 130

Sunmax FULLSGEN With Lidocaine – Product Description 130

SunMax Biotechnology Co Ltd – Ongoing Clinical Trials Overview 131

Sunmax FACIALGAIN Collagen Implant With Lidocaine – Evaluation of Collagen Dermal Filler with Lidocaine for the Correction of Nasolabial Folds: A Prospective, Randomized, Active-controlled, Double Blinded, Multicenter Clinical Trial 132

Sunmax FULLSGEN With Lidocaine – Evaluation of Collagen Dermal Filler with Lidocaine for the Correction of Nasolabial Folds: A Prospective, Randomized, Active-controlled, Double Blinded, Multicenter Clinical Trial 133

TEI Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 134

Injectable Dermal Filler – Product Status 134

Injectable Dermal Filler – Product Description 134

Tempo Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 135

MAP Tissue Scaffold-Based Dermal Filler – Product Status 135

MAP Tissue Scaffold-Based Dermal Filler – Product Description 135

Teoxane SA Pipeline Products & Ongoing Clinical Trials Overview 136

Teosyal RHA 1 – Product Status 136

Teosyal RHA 1 – Product Description 136

Teoxane SA – Ongoing Clinical Trials Overview 137

Teosyal RHA 1 – A Prospective, Multicentric, Open-labelled, Interventional Study to Assess Skin Beautification by Treating Fine Lines in the Neck, Perioral and Smiling Lines Areas With TEOSYAL RHA 1 138

Teosyal RHA 1 – A Prospective, Single Blind, Single-center Study Evaluating the Histology and Intradermal Implantation of the Teosyal RHA Collection of Fillers 138

Tissueform Inc Pipeline Products & Ongoing Clinical Trials Overview 139

PureVoluma – Product Status 139

PureVoluma – Product Description 139

University of California Santa Barbara Pipeline Products & Ongoing Clinical Trials Overview 140

Needle Free Injector – Product Status 140

Needle Free Injector – Product Description 140

Glossary 144

List of Figures

Aesthetic Injectables – Pipeline Products by Stage of Development 14

Aesthetic Injectables – Pipeline Products by Segment 15

Aesthetic Injectables – Pipeline Products by Territory 16

Aesthetic Injectables – Pipeline Products by Regulatory Path 17

Aesthetic Injectables – Pipeline Products by Estimated Approval Date 18

Aesthetic Injectables – Ongoing Clinical Trials 19

    Pricing

Discounts available for multiple purchases.

reportstore@globaldata.com
+44 20 7947 2960

Join our mailing list

Saved reports